Chemoinformaics analysis of Cyclopropaneoctanoic acid-2-octyl-Methyl Ester
| Molecular Weight | 310.522 | nRot | 15 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 4 |
| Exact Molecular Weight | 310.287 | nRing | 1 |
| Solubility: LogS | -6.89 | nHRing | 0 |
| Solubility: LogP | 7.497 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 60.3421 |
| nHD | 0 | BPOL | 40.7259 |
| QED | 0.263 |
| Synth | 2.896 |
| Natural Product Likeliness | 0.818 |
| NR-PPAR-gamma | 0.039 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.029 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.781 |
| MDCK | 0.0000159 |
| BBB | 0.159 |
| PPB | 0.97346 |
| VDSS | 2.587 |
| FU | 0.0113406 |
| CYP1A2-inh | 0.32 |
| CYP1A2-sub | 0.218 |
| CYP2c19-inh | 0.372 |
| CYP2c19-sub | 0.144 |
| CYP2c9-inh | 0.267 |
| CYP2c9-sub | 0.924 |
| CYP2d6-inh | 0.131 |
| CYP2d6-sub | 0.08 |
| CYP3a4-inh | 0.703 |
| CYP3a4-sub | 0.119 |
| CL | 5.999 |
| T12 | 0.202 |
| hERG | 0.256 |
| Ames | 0.005 |
| ROA | 0.012 |
| SkinSen | 0.962 |
| Carcinogencity | 0.048 |
| EI | 0.943 |
| Respiratory | 0.871 |
| NR-Aromatase | 0.05 |
| Antiviral | Yes |
| Prediction | 0.589173 |